BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1870842)

  • 1. Anticataractogenic property of gamma-glutamylcysteine ethyl ester in an animal model of cataract.
    Ohtsu A; Kitahara S; Fujii K
    Ophthalmic Res; 1991; 23(1):51-8. PubMed ID: 1870842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage.
    MÃ¥rtensson J; Steinherz R; Jain A; Meister A
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8727-31. PubMed ID: 2813421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice.
    Calvin HI; Medvedovsky C; Worgul BV
    Science; 1986 Aug; 233(4763):553-5. PubMed ID: 3726547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin.
    Li ZR; Reiter RJ; Fujimori O; Oh CS; Duan YP
    J Pineal Res; 1997 Apr; 22(3):117-23. PubMed ID: 9213264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats.
    Maitra I; Serbinova E; Tritschler HJ; Packer L
    Biochem Biophys Res Commun; 1996 Apr; 221(2):422-9. PubMed ID: 8619871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
    Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
    Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of human and rat lenticular glutathione in vitro by prodrugs of gamma-L-glutamyl-L-cysteine.
    Nagasawa HT; Cohen JF; Holleschau AM; Rathbun WB
    J Med Chem; 1996 Apr; 39(8):1676-81. PubMed ID: 8648607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of glutathione, as gamma-glutamylcysteinylglycyl ester, into liver and kidney.
    Puri RN; Meister A
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5258-60. PubMed ID: 6577420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of mouse buthionine sulfoximine cataracts in vitro is inhibited by thiols or ascorbate.
    Calvin HI; Zhu G; Wu J; Banerjee U; Fu JS
    Exp Eye Res; 1997 Sep; 65(3):341-7. PubMed ID: 9299171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lens GSH depletion and electrolyte changes preceding cataracts induced by buthionine sulfoximine in suckling mice.
    Calvin HI; von Hagen S; Hess JL; Patel SA; Fu SC
    Exp Eye Res; 1992 Apr; 54(4):621-6. PubMed ID: 1623947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in rat brain glutathione following intracerebroventricular administration of gamma-glutamylcysteine.
    Pileblad E; Magnusson T
    Biochem Pharmacol; 1992 Sep; 44(5):895-903. PubMed ID: 1530658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glutathione turnover in drug sulfation: differential effects of diethylmaleate and buthionine sulfoximine on the pharmacokinetics of acetaminophen in the rat.
    Galinsky RE
    J Pharmacol Exp Ther; 1986 Jan; 236(1):133-9. PubMed ID: 3941389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts.
    Packer L
    Ann N Y Acad Sci; 1994 Nov; 738():257-64. PubMed ID: 7832436
    [No Abstract]   [Full Text] [Related]  

  • 14. UV-b-induced cataract model in brown-Norway rat eyes combined with preadministration of buthionine sulfoximine.
    Hatano T; Kojima M
    Ophthalmic Res; 1996; 28 Suppl 2():54-63. PubMed ID: 8883090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide.
    Carey JW; Pinarci EY; Penugonda S; Karacal H; Ercal N
    Free Radic Biol Med; 2011 Mar; 50(6):722-9. PubMed ID: 21172425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The inhibitory effect of gamma-glutamylcysteinylethyl ester (gamma-GCE) instillation on experimental diabetic cataract formation in rats].
    Hattori H; Majima Y; Fukami H; Torii H; Nagamura Y; Ishiguro I; Ohta Y
    Nippon Ganka Gakkai Zasshi; 1991 Mar; 95(3):228-34. PubMed ID: 1831318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats.
    Maitra I; Serbinova E; Trischler H; Packer L
    Free Radic Biol Med; 1995 Apr; 18(4):823-9. PubMed ID: 7750805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione metabolism at the blood-cerebrospinal fluid barrier.
    Anderson ME; Underwood M; Bridges RJ; Meister A
    FASEB J; 1989 Nov; 3(13):2527-31. PubMed ID: 2572501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early epithelial lesions in cataracts of GSH-depleted mouse pups.
    Laver NM; Robison WG; Calvin HI; Fu SC
    Exp Eye Res; 1993 Oct; 57(4):493-8. PubMed ID: 8282035
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin.
    Abe M; Reiter RJ; Orhii PB; Hara M; Poeggeler B
    J Pineal Res; 1994 Sep; 17(2):94-100. PubMed ID: 7869232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.